Navigation Links
Do Jerusalem's Arabs and Jews receive a different quality of medical care?
Date:1/25/2008

Researchers Amit Tirosh, Bmed, Ronit Calderon-Margalit, MD, MPH, Marianna Mazar, MD and Zvi Stern, MD compared the quality of care delivered to Jewish and Arab diabetes sufferers who were admitted to four major hospital emergency rooms in Jerusalem, to evaluate whether differences existed between the two groups and, if they did, their causes, given the common basis of health insurance coverage. The researchers found significant differences. As compared to the Jewish patients, Arab patients received:

  • less diet counseling
  • fewer recommendations and less support for physical activity
  • less guidance in performing self foot examinations
  • fewer medications prescribed

Quality of care of Arab patients with diabetes is lower than that received by Jewish patients in the city, write the authors in the article. Resources should be invested in early detection of diabetes among the Arab population and in intensive treatment following diagnosis, together with lifestyle modifications to improve the quality of life among Arab patients with diabetes and to decrease the economic burden of the disease.


'/>"/>

Contact: Andrea Rulfo
media.inquiries@sagepub.com
805-410-7150
SAGE Publications
Source:Eurekalert

Page: 1

Related medicine news :

1. Eleven Florida Nonprofit Organizations to Receive Grants Totaling Nearly $1 Million From The Blue Foundation
2. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
3. Siemens Receives FDA 510(K) Clearance for Next Generation Radiation Therapy Solution
4. ImmunoVaccine Technologies Receives $3 Million From ACOA
5. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
6. Students Pursuing Health Care Careers Receive $24,000 in Scholarships From National Hispanic Health Foundation
7. Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
8. MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS
9. Researcher, magnet lab receive $2 million grant to target tuberculosis
10. Novadaqs SPY System receives clearance for use in organ transplant surgery
11. Philadelphia Policeman Helps Amputee Receive Power Wheelchair from The Scooter Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: